Works matching AU Ro, Jungsil


Results: 72
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress.

    Published in:
    2016
    By:
    • Hyun-Ah Kim;
    • Sei Hyun Ahn;
    • Seok Jin Nam;
    • Seho Park;
    • Jungsil Ro;
    • Seock-Ah Im;
    • Yong Sik Jung;
    • Jung Han Yoon;
    • Min Hee Hur;
    • Yoon Ji Choi;
    • Soo-Jung Lee;
    • Joon Jeong;
    • Se-Heon Cho;
    • Sung Yong Kim;
    • Min Hyuk Lee;
    • Lee Su Kim;
    • Byung-In Moon;
    • Tae Hyun Kim;
    • Chanheun Park;
    • Sei Joong Kim
    Publication type:
    journal article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.

    Published in:
    Oncologist, 2017, v. 22, n. 9, p. 1028, doi. 10.1634/theoncologist.2017-0072
    By:
    • Loibl, Sibylle;
    • Turner, Nicholas C.;
    • Ro, Jungsil;
    • Cristofanilli, Massimo;
    • Iwata, Hiroji;
    • Im, Seock‐Ah;
    • Masuda, Norikazu;
    • Loi, Sherene;
    • André, Fabrice;
    • Harbeck, Nadia;
    • Verma, Sunil;
    • Folkerd, Elizabeth;
    • Puyana Theall, Kathy;
    • Hoffman, Justin;
    • Zhang, Ke;
    • Bartlett, Cynthia Huang;
    • Dowsett, Mitchell
    Publication type:
    Article
    22

    Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).

    Published in:
    Oncologist, 2016, v. 21, n. 10, p. 1165, doi. 10.1634/theoncologist.2016-0097
    By:
    • Verma, Sunil;
    • Bartlett, Cynthia Huang;
    • Schnell, Patrick;
    • DeMichele, Angela M.;
    • Loi, Sherene;
    • Ro, Jungsil;
    • Colleoni, Marco;
    • Iwata, Hiroji;
    • Harbeck, Nadia;
    • Cristofanilli, Massimo;
    • Zhang, Ke;
    • Thiele, Alexandra;
    • Turner, Nicholas C.;
    • Rugo, Hope S.
    Publication type:
    Article
    23
    24
    25

    A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2017, v. 165, n. 3, p. 601, doi. 10.1007/s10549-017-4375-5
    By:
    • Rugo, Hope;
    • Trédan, Olivier;
    • Ro, Jungsil;
    • Morales, Serafin;
    • Campone, Mario;
    • Musolino, Antonino;
    • Afonso, Noémia;
    • Ferreira, Marta;
    • Park, Kyong;
    • Cortes, Javier;
    • Tan, Antoinette;
    • Blum, Joanne;
    • Eaton, Lamar;
    • Gause, Christine;
    • Wang, Zhen;
    • Im, Ellie;
    • Mauro, David;
    • Jones, Mary;
    • Denker, Andrew;
    • Baselga, José
    Publication type:
    Article
    26

    Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02).

    Published in:
    Breast Cancer Research & Treatment, 2015, v. 152, n. 1, p. 77, doi. 10.1007/s10549-015-3450-z
    By:
    • Park, Yeon;
    • Jung, Kyung;
    • Im, Seock-Ah;
    • Sohn, Joo;
    • Ro, Jungsil;
    • Ahn, Jin-Hee;
    • Kim, Sung-Bae;
    • Nam, Byung-Ho;
    • Oh, Do;
    • Han, Sae-Won;
    • Lee, Soohyeon;
    • Park, In;
    • Lee, Keun;
    • Kim, Jee;
    • Kang, Seok;
    • Lee, Moon;
    • Park, Hee;
    • Woo, Sook;
    • Jung, Sin-Ho;
    • Ahn, Jin
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50